Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems
Among those with available data, 70.6% of first-time anti-diabetic medication prescriptions in June 2024 had a fill within 60 days (69.5% overall)
These side effects include nausea, vomiting, and low blood sugar levels which can be fatal if not treated quickly
Retatrutide is not recommended for: Individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 Pregnant or breastfeeding individuals Those with severe gastrointestinal disorders or pancreatitis Anyone not enrolled in a supervised clinical trial Always consult a licensed medical provider before considering any investigational therapy
GLP-1 agonists may be oral or injectable depending on the medication prescribed by your provider
US$ 27.94
US$ 21.92
US$ 20.85
US$ 29.10
